ライフサイエンスコーパス: transurethral

1 s of immunization: subcutaneous, intranasal, transurethral, and oral.

2 infection provided urine samples by voided, transurethral, and/or suprapubic collection methods.

3 nosis remains cystoscopic visualization with transurethral biopsy or resection.

4 botics to improve the safety and outcomes of transurethral bladder surgery and surveillance, further

5 l system to enhance bladder surveillance and transurethral bladder tumor, a purpose-specific robotic

6 -80 mm Hg, 20 s) air UBD was delivered via a transurethral catether and extracellular single-unit rec

7 e common in voided urine, urine collected by transurethral catheter (TUC), and urine collected by sup

8 Bladder activity was recorded via a transurethral catheter during continuous infusion (0.21

9 073 in the bladders and/or kidneys following transurethral cochallenge (P <or= 0.0139).

10 l able to compete with wild-type CFT073 in a transurethral cochallenge in mice and could colonize the

11 ils to compete with wild-type CFT073 after a transurethral cochallenge in mice and is deficient in th

12 Virulence was assessed by transurethral cochallenge of CBA mice with wild-type and

13 r transurethral resection of the prostate or transurethral electrovaporization of the prostate and ha

14 h formalin-killed bacteria and intranasal or transurethral immunization with purified MR/P fimbriae s

15 ive procedures such as urethral dilation and transurethral incision of the bladder neck may be improv

16 Virulence was assessed by transurethral independent challenges and cochallenges of

17 Following transurethral infection of CBA mice with a sat mutant, n

18 ign prostatic hyperplasia, transperineal and transurethral injection routes have received the most sy

19 Transurethral inoculation of P. mirabilis(pBAC001) resul

20 noculum preparation on the day of infection, transurethral inoculation, tissue harvest and post-harve

21 However, the transurethral laser enucleation of the prostate addresse

22 the safety, effectiveness, and durability of transurethral microwave thermotherapy (TUMT) as a minima

23 s of mice at significantly lower levels in a transurethral model of infection.

24 pendectomy, hemorrhoidectomy, thyroidectomy, transurethral prostate surgery, parathyroidectomy, and c

25 n 47 men undergoing radical prostatectomy or transurethral prostatectomy at Loyola University Medical

26 rior eye, intramedullary spine, and possibly transurethral prostatectomy surgery.

27 Electrosurgical transurethral resection (TUR) of the prostate (TURP) has

28 Transurethral resection and instillation of perioperativ

29 carcinomas of the bladder were treated with transurethral resection and intravesical bacillus Calmet

30 rficial bladder cancer is still managed with transurethral resection and perioperative instillation o

31 patients who underwent either enucleation or transurethral resection as their initial treatment.

32 Transurethral resection biopsies of the prostatic urethr

33 e bladder cancer, combined-modality therapy (transurethral resection bladder tumor [TURBT], radiation

34 of those rendered T(1) at second look after transurethral resection bladder tumor, most still requir

35 than five cases in urologists, with previous transurethral resection experience.

36 Bipolar transurethral resection is a novel approach in treatment

37 nstillation of chemotherapeutic agents after transurethral resection is quickly becoming the standard

38 Despite current treatment after transurethral resection of a bladder tumor, recurrences

39 sparing trimodal therapy (TMT) that combines transurethral resection of bladder tumor, chemotherapy f

40 Concurrently performed transurethral resection of bladder tumor-TURP seems onco

41 All patients had transurethral resection of bladder tumour and twice-dail

42 Age (P =.78), race (P =.29), prior transurethral resection of prostate (P =.81), and treatm

43 as admitted with massive hematuria following transurethral resection of prostate for benign prostatic

44 of the procedures examined (P < .01, except transurethral resection of prostate, P = .76).

45 radiation delivered per treatment, and prior transurethral resection of prostate.

46 All patients underwent transurethral resection of the bladder (TURB) and had hi

47 Patients who received no LT, transurethral resection of the bladder tumor alone, or <

48 A transurethral resection of the bladder tumor and biopsy

49 ons and partial obstructions respond best to transurethral resection of the ejaculatory ducts (TURED)

50 rlson comorbidity score (P < .01), and prior transurethral resection of the prostate (OR, 1.65; P < .

51 state glands (> or = 60 cm3) or history of a transurethral resection of the prostate (TURP) as implan

52 Transurethral resection of the prostate (TURP) has long

53 with age, suggests that the frequent use of transurethral resection of the prostate (TURP) in recent

54 alised prostate cancer diagnosed by use of a transurethral resection of the prostate (TURP) in the UK

55 Eight percent of patients underwent a transurethral resection of the prostate (TURP) within 2

56 eks after radical prostatectomy (trial 1) or transurethral resection of the prostate (TURP; trial 2)

57 ent choice over the past 10 years, replacing transurethral resection of the prostate as the standard

58 on and catheter removal policy can result in transurethral resection of the prostate being performed

59 Optimizing each stage of transurethral resection of the prostate can result in re

60 rospective study of healthy men undergoing a transurethral resection of the prostate for benign prost

61 The new technique of bipolar transurethral resection of the prostate has been studied

62 ht to the market over the past decade or so, transurethral resection of the prostate has been undergo

63 At the same time, transurethral resection of the prostate has evolved into

64 i-centre studies in effectiveness of bipolar transurethral resection of the prostate is apparent.

65 the prostate are not as effective as either transurethral resection of the prostate or transurethral

66 sion of interest in surgical alternatives to transurethral resection of the prostate over the past de

67 In total, 156 prostate tissues from transurethral resection of the prostate procedures for b

68 Transurethral resection of the prostate remains a widely

69 Transurethral resection of the prostate remains the gold

70 Transurethral resection of the prostate remains the trea

71 Like many of the surgical alternatives to transurethral resection of the prostate this procedure s

72 sks the question of whether it will relegate transurethral resection of the prostate to an operation

73 -term results suggest equivalent efficacy to transurethral resection of the prostate with improved sa

74 agement was once limited to medical therapy, transurethral resection of the prostate, or open, relati

75 benign prostatic hyperplasia continues to be transurethral resection of the prostate, which is tradit

76 tatic outcomes compared to classic monopolar transurethral resection of the prostate.

77 dies have compared these two techniques with transurethral resection of the prostate.

78 tic hyperplasia was the electrocautery-based transurethral resection of the prostate.

79 tioned between pharmacological treatment and transurethral resection of the prostate.

80 e deemed high surgical risks for traditional transurethral resection of the prostate.

81 ajor advances that have occurred recently in transurethral resection of the prostate.

82 t challenge to the 'gold standard' status of transurethral resection of the prostate.

83 ggest there is no significant advantage over transurethral resection of the prostate.

84 etween June 2000 and July 2001 pertaining to transurethral resection of the prostate.

85 nt of superficial bladder cancer is based on transurethral resection of the tumor with perioperative

86 Both transurethral resection of the ureteral orifice (pluck)

87 RECENT FINDINGS: For improving transurethral resection quality, new optical enhancement

88 Transurethral resection remains the surgical mainstay fo

89 ime, a cystoscopy of his primary tumor and a transurethral resection revealed residual muscle-invasiv

90 itoring of irrigant absorption can eliminate transurethral resection syndrome.

91 Only randomized comparisons with transurethral resection will tell us if it is a worthy c

92 -sparing trimodality treatment consisting of transurethral resection with chemoradiation.

93 ients with high-risk NMIBC involves complete transurethral resection with intravesical BCG therapy.

94 ontinues to be managed predominantly through transurethral resection with perioperative instillation

95 Two to 4 weeks after complete transurethral resection, gemcitabine was administered in

96 mainstay of diagnosis remains cystoscopy and transurethral resection, with enhanced optical technique

97 ncer with particularly high recurrence after transurethral resection.

98 a safe, effective and durable alternative to transurethral resection.

99 f targeting of necrotic tissue from previous transurethral resections or chemotherapy are considered

100 nd based on radical prostatectomy samples or transurethral resections rather than biopsy samples.

101 lenocytes isolated from mice infected by the transurethral route robustly expressed IL-17A in respons

102 reports using transperineal, transrectal and transurethral routes with different injectables.

103 University are reviewed, including a robotic transurethral system to enhance bladder surveillance and

104 Bladder preservation with transurethral tumour resection, radiation, and chemother

105 nosis is established by urinary cytology and transurethral tumour resection.

106 With the advent of the high resolution transurethral ultrasound (TRUS) technology, there has be

107 MR imaging-controlled transurethral ultrasound therapy is feasible, safe, and

108 Transurethral ultrasound therapy was performed with the

109 Topics discussed include transurethral vaporization of the prostate, laser prosta